November 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Romy Meier: From Research to New Scientific Perspectives on HIT and VITT

AI Generated

Nov 12, 2026, 09:57

Romy Meier: From Research to New Scientific Perspectives on HIT and VITT

Romy Meier, Scientist at TNO, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Thrombosis and Haemostasis, adding:

“After 7 years (of which my PhD took up the last 4.5 years), 6 peer-reviewed publications (and counting) and numerous conferences and collaborations, it was time to say goodbye to Sanquin .

I can look back on a memorable time with both challenges and many special and valuable encounters and experiences.

Of course, this wouldn’t have been possible without the supervision of Rick Kapur and Masja de Haas, and the tremendous efforts of Carolien Zeelen, Suzanne Hofstede-van Egmond and all the others whom I’ve had the pleasure of working with.

I’m very proud of all the work we did. Thank you!

For those interested in what I did during my PhD, check out the review we published focusing on the pathophysiology of Heparin-Induced Thrombocytopenia (HIT) and Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT).

Saying goodbye also made room for a next step, and I’m happy and excited to share that I started as a scientist at TNO in September.

Looking forward to what’s ahead, and of course to my PhD defense, which is yet to be scheduled. So stay tuned!”

Title: Antibody-mediated multicellular pathophysiology of heparin-induced thrombocytopenia and vaccine-induced thrombotic thrombocytopenia: the dynamic roles of platelets, neutrophils, endothelial cells, and monocytes

Authors: Romy T. Meier, Rick Kapur

Romy Meier: From Research to New Scientific Perspectives on HIT and VITT